SABLICH KIM (Chief Commercial Officer) sold 3.9% of their position (2.58K shares) of MYOVANT SCIENCES LTD. on the open market
Open‑market sale worth $41.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/19/2019ACC: 0001209191-19-061300
Officer· Chief Commercial Officer
Since Dec 2018
-2.58K
Net shares
Net seller
$41.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.58K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.58K
Price / share
$16.22
Trade value
$41.93K
% of position
3.9%
12/18/2019
67.11K→64.53K
Total
Net shares
−2.58K
Net value
-$41.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2019 | S · Sale | −2.58K | $16.22 | $41.93K | 3.9% | 67.11K | 64.53K |
| Total | −2.58K | -$41.93K | ||||||
Derivative Transactions0
No derivative transactions reported